Control of B Lymphocyte Apoptosis by the Transcription Factor NF-κB

Immunity

Volumn 25, Issue 6, 2006, Pages 871-883

  Sen, Ranjan ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BIM PROTEIN; BRUTON TYROSINE KINASE; CD19 ANTIGEN; CD23 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLIN E; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 10; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; UNINDEXED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; APOPTOSIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL VIABILITY; DOWN REGULATION; GENE ACTIVATION; GERMINAL CENTER; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL SURVIVAL; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33845422163     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.12.003     Document Type: Review

References (133)

1. Aiba Y., Yamazaki T., Okada T., Gotoh K., Sanjo H., Ogata M., and Kurosaki T. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 24 (2006) 259-268
2. Amanna I.J., Dingwall J.P., and Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 170 (2003) 4593-4600
3. Amin R.H., and Schlissel M.S. NF-kappa B comes home. Immunity 22 (2005) 401-402
4. Andjelic S., Hsia C., Suzuki H., Kadowaki T., Koyasu S., and Liou H.C. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J. Immunol. 165 (2000) 3860-3867
5. Bajpai U.D., Zhang K., Teutsch M., Sen R., and Wortis H.H. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med. 191 (2000) 1735-1744
6. Banerjee D., and Sen R. Cellular dynamics of NF-kappaB associated proteins. In: Liou H.-C. (Ed). NF-kB/Rel Transcription Factor Family (2006), Landes Bioscience, Austin, TX 41-50
7. Barrington R.A., Zhang M., Zhong X., Jonsson H., Holodick N., Cherukuri A., Pierce S.K., Rothstein T.L., and Carroll M.C. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J. Immunol. 175 (2005) 2859-2867
8. Bidere N., Su H.C., and Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24 (2006) 321-352
9. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Aronow B.J., Ghosh G., Rickert R.C., and Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23 (2004) 4202-4210
10. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25 (2004) 280-288
11. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5 (2004) 1052-1060
12. Calderhead D.M., Kosaka Y., Manning E.M., and Noelle R.J. CD40-CD154 interactions in B-cell signaling. Curr. Top. Microbiol. Immunol. 245 (2000) 73-99
13. Cancro M.P., and Kearney J.F. B cell positive selection: Road map to the primary repertoire?. J. Immunol. 173 (2004) 15-19
14. Cariappa A., Liou H.C., Horwitz B.H., and Pillai S. Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192 (2000) 1175-1182
15. Chen C., Li H., Tian Q., Beardall M., Xu Y., Casanova N., and Weigert M. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176 (2006) 5183-5190
16. -/- B cells. Oncogene 22 (2003) 8472-8486
17. Chung J.B., Baumeister M.A., and Monroe J.G. Cutting edge: Differential sequestration of plasma membrane-associated B cell antigen receptor in mature and immature B cells into glycosphingolipid-enriched domains. J. Immunol. 166 (2001) 736-740
18. Chung J.B., Silverman M., and Monroe J.G. Transitional B cells: Step by step towards immune competence. Trends Immunol. 24 (2003) 343-349
19. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3 (2002) 958-965
20. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
21. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med. 202 (2005) 1363-1374
22. Crowley J.E., Treml L.S., Stadanlick J.E., Carpenter E., and Cancro M.P. Homeostatic niche specification among naive and activated B cells: A growing role for the BLyS family of receptors and ligands. Semin. Immunol. 17 (2005) 193-199
23. Culton D.A., O'Conner B.P., Conway K.L., Diz R., Rutan J., Vilen B.J., and Clarke S.H. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 176 (2006) 790-802
24. Dal Porto J.M., Gauld S.B., Merrell K.T., Mills D., Pugh-Bernard A.E., and Cambier J. B cell antigen receptor signaling 101. Mol. Immunol. 41 (2004) 599-613
25. Davis R.E., Brown K.D., Siebenlist U., and Staudt L.M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194 (2001) 1861-1874
26. Enders A., Bouillet P., Puthalakath H., Xu Y., Tarlinton D.M., and Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198 (2003) 1119-1126
27. Enzler T., Bonizzi G., Silverman G.J., Otero D.C., Widhopf G.F., Anzelon-Mills A., Rickert R.C., and Karin M. Alternative and Classical NF-kappaB Signaling Retain Autoreactive B Cells in the Splenic Marginal Zone and Result in Lupus-like Disease. Immunity 25 (2006) 403-415
28. Feng B., Cheng S., Hsia C.Y., King L.B., Monroe J.G., and Liou H.C. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell. Immunol. 232 (2004) 9-20
29. Foote L.C., Marshak-Rothstein A., and Rothstein T.L. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded. J. Exp. Med. 187 (1998) 847-853
30. Fox C.J., Hammerman P.S., Cinalli R.M., Master S.R., Chodosh L.A., and Thompson C.B. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 17 (2003) 1841-1854
31. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A., Grinberg A., Tran T., Scharton-Kersten T., Anver M., et al. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187 (1998) 147-159
32. Fuentes-Panana E.M., Bannish G., and Monroe J.G. Basal B-cell receptor signaling in B lymphocytes: mechanisms of regulation and role in positive selection, differentiation, and peripheral survival. Immunol. Rev. 197 (2004) 26-40
33. Fujimoto M., Poe J.C., Satterthwaite A.B., Wahl M.I., Witte O.N., and Tedder T.F. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. J. Immunol. 168 (2002) 5465-5476
34. Fujita N., Jaye D.L., Geigerman C., Akyildiz A., Mooney M.R., Boss J.M., and Wade P.A. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119 (2004) 75-86
35. Gerondakis S., and Strasser A. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin. Immunol. 15 (2003) 159-166
36. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., Bixler S.A., Su L., Scott M.L., and Kalled S.L. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 172 (2004) 762-766
37. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
38. Grossmann M., O'Reilly L.A., Gugasyan R., Strasser A., Adams J.M., and Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19 (2000) 6351-6360
39. Grumont R., Lock P., Mollinari M., Shannon F.M., Moore A., and Gerondakis S. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappaB-dependent c-myc expression. Immunity 21 (2004) 19-30
40. Grumont R.J., Rourke I.J., and Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13 (1999) 400-411
41. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., and Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187 (1998) 663-674
42. Hammerman P.S., Fox C.J., Cinalli R.M., Xu A., Wagner J.D., Lindsten T., and Thompson C.B. Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation. Cancer Res. 64 (2004) 8341-8348
43. Han S., Zheng B., Dal Porto J., and Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J. Exp. Med. 182 (1995) 1635-1644
44. Hande S., Notidis E., and Manser T. Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development. Immunity 8 (1998) 189-198
45. Hara H., Wada T., Bakal C., Kozieradzki I., Suzuki S., Suzuki N., Nghiem M., Griffiths E.K., Krawczyk C., Bauer B., et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18 (2003) 763-775
46. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
47. Hennino A., Berard M., Casamayor-Palleja M., Krammer P.H., and Defrance T. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells. J. Immunol. 165 (2000) 3023-3030
48. Hennino A., Berard M., Krammer P.H., and Defrance T. FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J. Exp. Med. 193 (2001) 447-458
49. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186
50. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298 (2002) 1241-1245
51. Huntington N.D., Xu Y., Puthalakath H., Light A., Willis S.N., Strasser A., and Tarlinton D.M. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat. Immunol. 7 (2006) 190-198
52. Jumaa H., Hendriks R.W., and Reth M. B cell signaling and tumorigenesis. Annu. Rev. Immunol. 23 (2005) 415-445
53. Jun J.E., and Goodnow C.C. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat. Immunol. 4 (2003) 1057-1064
54. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N., and Akira S. IkappaB kinase alpha is essential for mature B cell development and function. J. Exp. Med. 193 (2001) 417-426
55. Kane L.P., Lin J., and Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 23 (2002) 413-420
56. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
57. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 (2002) 515-524
58. King L.B., Norvell A., and Monroe J.G. Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J. Immunol. 162 (1999) 2655-2662
59. Koretzky G.A., Abtahian F., and Silverman M.A. SLP76 and SLP65: Complex regulation of signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6 (2006) 67-78
60. Kraus M., Alimzhanov M.B., Rajewsky N., and Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117 (2004) 787-800
61. Kuo P., Alban A., Gebhard D., and Diamond B. Overexpression of bcl-2 alters usage of mutational hot spots in germinal center B cells. Mol. Immunol. 34 (1997) 1011-1018
62. Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. Immunol. 2 (2002) 354-363
63. Lam K.P., Kuhn R., and Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90 (1997) 1073-1083
64. Lavrik I., Golks A., and Krammer P.H. Death receptor signaling. J. Cell Sci. 118 (2005) 265-267
65. Lawrence T., Bebien M., Liu G.Y., Nizet V., and Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
66. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., and Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289 (2000) 2350-2354
67. Levine M.H., Haberman A.M., Sant'Angelo D.B., Hannum L.G., Cancro M.P., Janeway Jr. C.A., and Shlomchik M.J. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc. Natl. Acad. Sci. USA 97 (2000) 2743-2748
68. Li Z.W., Omori S.A., Labuda T., Karin M., and Rickert R.C. IKK beta is required for peripheral B cell survival and proliferation. J. Immunol. 170 (2003) 4630-4637
69. Louzoun Y., Friedman T., Luning Prak E., Litwin S., and Weigert M. Analysis of B cell receptor production and rearrangement. Part I. Light chain rearrangement. Semin. Immunol. 14 (2002) 169-190
70. Marrack P., and Kappler J. Control of T cell viability. Annu. Rev. Immunol. 22 (2004) 765-787
71. McHeyzer-Williams L.J., Malherbe L.P., and McHeyzer-Williams M.G. Checkpoints in memory B-cell evolution. Immunol. Rev. 211 (2006) 255-268
72. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431 (2004) 456-461
73. Meffre E., and Nussenzweig M.C. Deletion of immunoglobulin beta in developing B cells leads to cell death. Proc. Natl. Acad. Sci. USA 99 (2002) 11334-11339
74. Mittal A., Papa S., Franzoso G., and Sen R. NF-kappaB-dependent regulation of the timing of activation-induced cell death of T lymphocytes. J. Immunol. 176 (2006) 2183-2189
75. Mizuno T., Zhong X., and Rothstein T.L. Fas-induced apoptosis in B cells. Apoptosis 8 (2003) 451-460
76. Monroe J.G. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 6 (2006) 283-294
77. Moore C.R., and Bishop G.A. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 175 (2005) 3780-3789
78. Narayan P., Holt B., Tosti R., and Kane L.P. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol. Cell. Biol. 26 (2006) 2327-2336
79. Newton K., and Dixit V.M. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13 (2003) 1247-1251
80. Oliver P.M., Vass T., Kappler J., and Marrack P. Loss of the proapoptotic protein, Bim, breaks B cell anergy. J. Exp. Med. 203 (2006) 731-741
81. Otero D.C., Omori S.A., and Rickert R.C. Cd19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276 (2001) 1474-1478
82. Owyang A.M., Tumang J.R., Schram B.R., Hsia C.Y., Behrens T.W., Rothstein T.L., and Liou H.C. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J. Immunol. 167 (2001) 4948-4956
83. Pasparakis M., Schmidt-Supprian M., and Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196 (2002) 743-752
84. Patke A., Mecklenbrauker I., Erdjument-Bromage H., Tempst P., and Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC{beta}- and Akt-dependent mechanism. J. Exp. Med. 203 (2006) 2551-2562
85. Petro J.B., Rahman S.M., Ballard D.W., and Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 191 (2000) 1745-1754
86. Phan R.T., and Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432 (2004) 635-639
87. Phan R.T., Saito M., Basso K., Niu H., and Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 6 (2005) 1054-1060
88. Pikarsky E., and Ben-Neriah Y. NF-kappaB inhibition: A double-edged sword in cancer?. Eur. J. Cancer 42 (2006) 779-784
89. Pulendran B., Kannourakis G., Nouri S., Smith K.G., and Nossal G.J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375 (1995) 331-334
90. Qian Y., Qin J., Cui G., Naramura M., Snow E.C., Ware C.F., Fairchild R.L., Omori S.A., Rickert R.C., Scott M., et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21 (2004) 575-587
91. Rahman Z.S., Rao S.P., Kalled S.L., and Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 198 (2003) 1157-1169
92. Rathmell J.C., Cooke M.P., Ho W.Y., Grein J., Townsend S.E., Davis M.M., and Goodnow C.C. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376 (1995) 181-184
93. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17 (2005) 237-243
94. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S.T., and Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374 (1995) 163-165
95. Ruefli-Brasse A.A., French D.M., and Dixit V.M. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 302 (2003) 1581-1584
96. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., and Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104 (2001) 33-42
97. Saccani S., Marazzi I., Beg A.A., and Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 200 (2004) 107-113
98. Sandel P.C., and Monroe J.G. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10 (1999) 289-299
99. Sasaki Y., Derudder E., Hobeika E., Pelanda R., Reth M., Rajewsky K., and Schmidt-Supprian M. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24 (2006) 729-739
100. Scharschmidt E., Wegener E., Heissmeyer V., Rao A., and Krappmann D. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol. Cell. Biol. 24 (2004) 3860-3873
101. Schmitz M.L., and Krappmann D. Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ. 13 (2006) 834-842
102. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 (2001) 1495-1499
103. Shapiro-Shelef M., and Calame K. Plasma cell differentiation and multiple myeloma. Curr. Opin. Immunol. 16 (2004) 226-234
104. Shokat K.M., and Goodnow C.C. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375 (1995) 334-338
105. Siebenlist U., Brown K., and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 5 (2005) 435-445
106. Smith S.H., and Cancro M.P. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J. Immunol. 170 (2003) 5820-5823
107. Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 189-200
108. Su T.T., Guo B., Wei B., Braun J., and Rawlings D.J. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197 (2004) 161-178
109. Su T.T., and Rawlings D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168 (2002) 2101-2110
110. Takahashi Y., Ohta H., and Takemori T. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14 (2001) 181-192
111. Takeuchi O., Fisher J., Suh H., Harada H., Malynn B.A., and Korsmeyer S.J. Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc. Natl. Acad. Sci. USA 102 (2005) 11272-11277
112. Thomas M.D., Srivastava B., and Allman D. Regulation of peripheral B cell maturation. Cell. Immunol. 239 (2006) 92-102
113. Tze L.E., Schram B.R., Lam K.P., Hogquist K.A., Hippen K.L., Liu J., Shinton S.A., Otipoby K.L., Rodine P.R., Vegoe A.L., et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol. 3 (2005) e82
114. van Eijk M., Medema J.P., and de Groot C. Cutting edge: Cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions. J. Immunol. 166 (2001) 6473-6476
115. Venkataraman L., Burakoff S.J., and Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181 (1995) 1091-1099
116. Verkoczy L., Ait-Azzouzene D., Skog P., Martensson A., Lang J., Duong B., and Nemazee D. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22 (2005) 519-531
117. Victoratos P., Lagnel J., Tzima S., Alimzhanov M.B., Rajewsky K., Pasparakis M., and Kollias G. FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity 24 (2006) 65-77
118. Vora K.A., Wang L.C., Rao S.P., Liu Z.Y., Majeau G.R., Cutler A.H., Hochman P.S., Scott M.L., and Kalled S.L. Cutting edge: Germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J. Immunol. 171 (2003) 547-551
119. Wang J., Lobito A.A., Shen F., Hornung F., Winoto A., and Lenardo M.J. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J. Immunol. 30 (2000) 155-163
120. Wang Y., Brooks S.R., Li X., Anzelon A.N., Rickert R.C., and Carter R.H. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17 (2002) 501-514
121. Wang Y., and Carter R.H. CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 22 (2005) 749-761
122. Weil R., and Israel A. Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ. 13 (2006) 826-833
123. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
124. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 (2004) 694-699
125. William J., Euler C., Primarolo N., and Shlomchik M.J. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol. 176 (2006) 2142-2151
126. Williams S.A., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Verdin E., and Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25 (2006) 139-149
127. Woodland R.T., Schmidt M.R., and Thompson C.B. BLyS and B cell homeostasis. Semin. Immunol. 18 (2006) 318-326
128. Xue L., Morris S.W., Orihuela C., Tuomanen E., Cui X., Wen R., and Wang D. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4 (2003) 857-865
129. Yamazaki T., and Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat. Immunol. 4 (2003) 780-786
130. Zarnegar B., He J.Q., Oganesyan G., Hoffmann A., Baltimore D., and Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. USA 101 (2004) 8108-8113
131. Zazzeroni F., Papa S., Algeciras-Schimnich A., Alvarez K., Melis T., Bubici C., Majewski N., Hay N., De Smaele E., Peter M.E., and Franzoso G. Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood 102 (2003) 3270-3279
132. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9 (2002) 625-636
133. Zhu N., Ramirez L.M., Lee R.L., Magnuson N.S., Bishop G.A., and Gold M.R. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J. Immunol. 168 (2002) 744-754